India’s booming domestic pharma market expands 18%

INDIA – India’s domestic pharma market has registered a robust growth of nearly 18 percent. The country was hit by a devastating second wave of the COVID-19 pandemic and moved swiftly to vaccinate a majority of its population. According to India Ratings and Research (Ind-Ra), the 18 percent year-on-year revenue growth in India’s pharmaceutical market (IPM) in August was driven by improved sales in the non-covid product portfolio, while sales traction in the covid products remained stable. The COVID-19 influence portfolio contributed 37 percent to IPM for July 2021 moving…

Read More